GlaxoSmithKline

Sugar tax – a ‘sin tax’ that could help fat people get thin?

 Sugar is marketed worldwide as a health food. Research suggests it is anything but.  It is often called ‘white poison’. In excess, the white stuff is shown to be unhealthy, to say the least. It causes obesity, say researchers, that in turn raises your risk of  hypertension, heart disease, stroke, even cancer, musculoskeletal disorders and dementia, … Read more

Sanlam’s second Malaysian deal and Net1’s share bounce

First Avenue’s Matthew Warren is a Sanlam fan. Even more so after today’s R1,25bn acquisition of a controlling stake in a Malaysian life assurer, the group’s second investment in the South East Asian country in the past year. In our interview today on CNBC Africa’s Power Lunch, Warren explained why he is holding tight onto … Read more

Adcock Ingram, Hulamin, Aspen and more: Expert analysis from David Shapiro

In order to succeed in the stock markets, you have to be able to assess how news will affect the various companies available for investment. Few are better at accurately analysing South African shares than David Shapiro, deputy chairman of Sasfin Securities. David is, I reckon, at his best when he is dissecting the Johannesburg … Read more

Drug companies to work together to speed up new products

  Here’s a nice change:  profit-driven multinational pharmaceutical companies are seeing the value in collaboration and co-operation with competitors, it seems, to  get new medicines onto the market sooner. Here’s hoping they spend just as much quality time making sure those medicines are safe, and don’t wait for the drugs  to kill people before they … Read more

BizNews